These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 8691967)

  • 1. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.
    Waldo AL; Camm AJ; deRuyter H; Friedman PL; MacNeil DJ; Pauls JF; Pitt B; Pratt CM; Schwartz PJ; Veltri EP
    Lancet; 1996 Jul; 348(9019):7-12. PubMed ID: 8691967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?
    Pratt CM; Camm AJ; Cooper W; Friedman PL; MacNeil DJ; Moulton KM; Pitt B; Schwartz PJ; Veltri EP; Waldo AL
    Am J Cardiol; 1998 Apr; 81(7):869-76. PubMed ID: 9555777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design, and methods (the SWORD trial).
    Waldo AL; Camm AJ; deRuyter H; Freidman PL; MacNeil DJ; Pitt B; Pratt CM; Rodda BE; Schwartz PJ
    Am J Cardiol; 1995 May; 75(15):1023-7. PubMed ID: 7747682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Sotalol: death by the SWORD or deserving of further consideration for clinical use?
    Doggrell SA; Brown L
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1625-34. PubMed ID: 11060766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
    Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P
    Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SWORD trial of d-sotalol.
    Ghali JK
    Lancet; 1996 Sep; 348(9030):827. PubMed ID: 8814008
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.
    Pacifico A; Hohnloser SH; Williams JH; Tao B; Saksena S; Henry PD; Prystowsky EN
    N Engl J Med; 1999 Jun; 340(24):1855-62. PubMed ID: 10369848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
    Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M
    Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SWORD trial of d-sotalol.
    Tan LB
    Lancet; 1996 Sep; 348(9030):827-8. PubMed ID: 8814009
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide.
    Mosller M
    Clin Cardiol; 1997 Aug; 20(8):704-10. PubMed ID: 9259163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antiarrhythmic efficacy and safety of d-sotalol in patients with ventricular tachycardia and a low ejection fraction.
    Koch KT; Düren DR; van Zwieten PA
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):437-43. PubMed ID: 8527354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical safety profile of sotalol in the treatment of arrhythmias.
    MacNeil DJ; Davies RO; Deitchman D
    Am J Cardiol; 1993 Aug; 72(4):44A-50A. PubMed ID: 8346726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
    Køber L; Bloch Thomsen PE; Møller M; Torp-Pedersen C; Carlsen J; Sandøe E; Egstrup K; Agner E; Videbaek J; Marchant B; Camm AJ;
    Lancet; 2000 Dec; 356(9247):2052-8. PubMed ID: 11145491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease.
    Boriani G; Lubinski A; Capucci A; Niederle R; Kornacewicz-Jack Z; Wnuk-Wojnar AM; Borggrefe M; Brachmann J; Biffi M; Butrous GS;
    Eur Heart J; 2001 Dec; 22(23):2180-91. PubMed ID: 11913480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study.
    Pfisterer ME; Klöter-Weber UC; Huber M; Osswald S; Buser PT; Skarvan K; Stulz PM
    Ann Thorac Surg; 1997 Oct; 64(4):1113-9. PubMed ID: 9354537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.
    Patel DJ; Purcell HJ; Fox KM
    Eur Heart J; 1999 Jan; 20(1):51-7. PubMed ID: 10075141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
    Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M;
    N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral sotalol on systemic hemodynamics and programmed electrical stimulation in patients with ventricular arrhythmias and structural heart disease.
    Winters SL; Kukin M; Pe E; Stewart D; Deitchman D; Gomes JA
    Am J Cardiol; 1993 Aug; 72(4):38A-43A. PubMed ID: 8346725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.